Ask the Experts
- Kidney Guy
- Polycystic Kidney Disease
- Wednesday, 17 February 2016
- Subscribe via email
Many of the clinical trials are negative or minimally effective (mTOR inhibitors, somatostatin, water therapy, HALT PKD blood pressure control) - even tolvaptan is only modestly effective. However, in your opinion might a combination strategy be better than a single agent alone. Are there any efforts underway to test this?
- Page :
- 1
There are no replies made for this post yet.
Be one of the first to reply to this post!
Be one of the first to reply to this post!